As tumours in more advanced tumour stage with both types of metastases are characterised by a significantly lower VEGF-C expression compared to patients with predominant retroperitoneal metastases, this may indicate a potential of VEGF-C to estimate the risk for early retroperitoneal metastases. This evidence concerns the gene VEGFC and neoplasm.